Cassava Technologies is on a mission and it’s not even subtle. If you weren’t paying attention, it’s all about boosting and then dominating an African AI ecosystem. The company has a deal ...

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is ...

Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...

The saga of Cassava Sciences' development of Alzheimer's disease therapy simufilam has come to its dismal end. The company has reported top-line data from a second phase 3 trial of the drug ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

DUBAI, UAE – Media OutReach Newswire – 5 May 2025 – Zindi, the leading professional network for data scientists and AI developers in emerging markets, is pleased to announce that it has signed a ...

Find out all the key statistics for Cassava Sciences, Inc. (SAVA), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

At close: June 18 at 4:00:01 PM EDT ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Samaná.- A 4.4 magnitude earthquake was registered at 9:12 p.m. on Wednesday night in the Atlantic Ocean, north-northwest of Las Terrenas, according to the National Seismology Center at the Autonomous ...